Fundamental analysis by بورس طارم about Stock دفرا on 7/22/2025

و Iran's injectable and pharmaceutical products in the spring, with the sale of 2 billion tomans, increased by 5 % over the same period last year. This growth, with the improvement of the profit margin, with a net profit of 2 billion tomans, was 2 percent. The net profit of the year was 2 billion tomans, which has been able to realize 2 % in one season in the spring of Dafra. According to the comparison between the June and spring sales report of this year and the same period last year and the winter season, symbols #Defra #Drug #Dalber #Caspian #Dabor #Danco #Danco and #Damidid, show the greatest monthly sales increase compared to their past times. #Dafra #Medicine 📱@Fardaname